In a first, five Indian pharma majors have joined hands to conduct phase-III clinical trials of investigational anti-viral drug Molnupiravir on mild Covid-19 patients. The companies include Dr Reddy's Laboratories Ltd, Cipla Ltd, Sun Pharmaceutical Industries Ltd, Torrent Pharmaceuticals Ltd and Emcure Pharmaceuticals Ltd.
Read full Post
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment